Current status of anticoagulation and thrombosis-related issues in mechanical valves

Texas Heart Institute Journal

Volumn 23, Issue 1, 1996, Pages 36-41

  Gray, Richard J ^a,b  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b REGIONS HOSPITAL   (United States)

Author keywords

anticoagulants; heart valve prosthesis; prothrombin time; thromboembolism; thrombolytic therapy; thromboplastin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; DIPYRIDAMOLE; FIBRINOLYTIC AGENT; HEPARIN; THROMBOPLASTIN; WARFARIN;

ANTICOAGULATION; CONFERENCE PAPER; HEART VALVE PROSTHESIS; HUMAN; THROMBOEMBOLISM; THROMBOSIS;

ANTICOAGULANTS; HEART VALVE PROSTHESIS; HUMANS; PROSTHESIS DESIGN; PROTHROMBIN TIME; THROMBOLYTIC THERAPY; THROMBOSIS;

EID: 0029960322     PISSN: 07302347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (34)

1. Hirsh J, Poller L, Deykin D, Levine M, Dalen JE. Optimal therapeutic range for oral anticoagulante [published erratum appears in Chest 1989;96:9621 Chest 1989;95(2 Suppl).5S-11S
2. Bussey HI, Force RW, Bianco TM, Leonard AD. Reliance on prothrombin time ratios causes significant errors in anticoagulation therapy. Arch Intern Med 1992;152:278-82.
3. Altman R, Rouvier J, Gurfinkel E, D'Ortencio O, Manzanel R, de La Fuente L, et al Comparison of two levels of anticoagulant therapy in patients with substitute heart valves. J Thorac Cardiovasc Surg 1991;101:427-31
4. Saour JN, Sieck JO, Mamo LA, Gallus AS Trial of different intensities of anticoagulation in patients with prosthetic heart valves. N Engl J Med 1990;322.428-32.
5. Chesebro JH, Fuster V, Elveback LR, McGoon DC, Pluth JR, Puga FJ, et al. Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. Am J Cardiol 1983,51:1537-41.
6. Turpie AG, Gent M, Laupacis A, Latour Y, Gunstensen J, Basile F, et al A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med 1993;329:524-9.
7. Harada Y, Imai Y, Kurosawa H, Ishihara K, Kawada M, Fukuchi S. Ten-year follow-up after valve replacement with the St. Jude Medical prosthesis in children. J Thorac Cardiovasc Surg 1990;100:175-80.
8. Boe SL, McNicholas KW, Olivier HF, Niguidula FN, Magovern GJ, Lemole GM. Thromboembolism in children with St. Jude Medical valves maintained on aspirin and Persantine. In. Matloff JM, editor. Cardiac valve replacement current status. Boston: Martinus Nijhoff Publishing, 1985:145-53.
9. Schaffer MS, Clarke DR, Campbell DN, Madigan CK, Wiggins JW Jr, Wolfe RR. The St. Jude Medical cardiac valve in infants and children role of anticoagulant therapy. J Am Coll Cardiol 1987,9 235-9
10. Sade RM, Crawford FA Jr, Fyfe DA, Stroud MR Valve prostheses in children: a reassessment of anticoagulation. J Thorac Cardiovasc Surg 1988,95:553-61
11. Bjork VO, Henze A. Ten years' experience with the BjorkShiley tilting disc valve. J Thorac Cardiovasc Surg 1979;78. 331-42.
12. Horstkotte D, Korfer R, Seipel L, Bircks W, Loogen F Late complications in patients with Bjork-Shiley and St. Jude Medical heart valve replacement. Circulation 1983;68(3 Pt 2)II-175-84.
13. Hirsh J, Deykin D, Poller L. "Therapeutic range" for oral anticoagulant therapy Chest 1986;89(2 Suppl):11S-15S.
14. Wilson DB, Dunn MI, Hassanein K. Low-intensity anticoagulation in mechanical cardiac prosthetic valves. Chest 1991; 100:1553-7.
15. Hirsh J, Dalen JE, Deykin D, Poller L. Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range Chest 1992;102(4 Suppl) 312S-326S
16. Vogt S, Hoffmann A, Roth J, Dubach P, Bertschmann W, Hasse J, et al. Heart valve replacement with the Bjork-Shiley and St Jude Medical prostheses a randomized comparison in 178 patients. Eur Heart J 1990;11:583-91.
17. DiSesa VJ, Collins JJ Jr, Cohn LH. Hematological complications with the St Jude valve and reduced-dose Coumadin. Ann Thorac Surg 1989;48:280-3.
18. Hartz RS, LoCicero J III, Kucich V, DeBoer A. O'Mara S, Meyers SN, et al. Comparative study of warfarin versus antiplatelet therapy in patients with a St. Jude Medical valve in the aortic position J Thorac Cardiovasc Surg 1986;92-684-90
19. Ribeiro PA, Al Zaibag M, Idris M, Al Kasab S, Davies G, Masrut E, et al. Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease. J Thorac Cardiovasc Surg 1986;91.92-8.
20. Horstkotte D, Schulte H, Bircks W, Strauer B Unexpected findings concerning thromboembolic complications and anticoagulation after complete 10 year follow up of patients with St. Jude Medical prostheses J Heart Valve Dis 1993; 2:291-301
21. Sethia B, Turner MA, Lewis S, Rodger RA, Bain WH. Fourteen years' experience with the Bjork-Shiley tilting disc prosthesis. J Thorac Cardiovasc Surg 1986;91:350-61.
22. Eberlein U, von der Emde J, Rein J, Esperer HD. Thromboembolic and bleeding complications after mitral valve replacement. Eur J Cardiothorac Surg 1990;4:605-12
23. Cortina JM, Martinell J, Artiz V, Fraile J, Rabago G Comparative clinical results with Omniscience (STM1), Medtronic-Hall, and Bjork-Shiley convexo-concave (70 degrees) prostheses in mitral valve replacement J Thorac Cardiovasc Surg 1986;91 174-83.
24. Vallep JL, Gonzalez-Santos JM, Albertos J, Riesgo MJ, Bastida ME, Rico MJ, et al. Eight years' experience with the Medtronic-Hall valve prosthesis. Ann Thorac Surg 1990,50 429-36
25. Beaudet RL, Poirier NL, Doyle D, Nakhle G, Gauvin C. The Medtronic-Hall cardiac valve. 7 1/2 years' clinical experience Ann Thorac Surg 1986;42:644-50.
26. Spencer FC, Trinkle JK, Reeves JT. Successful replacement of a thrombosed mitral ball-valve prosthesis. JAMA 1965;194: 1249-51.
27. Witchitz S, Veyrat C, Moisson P, Scheinman N, Rozenstajn L. Fibrinolytic treatment of thrombus on prosthetic heart valves Br Heart J 1980;44:545-54
28. Ledain LD, Ohayon JP, Colle JP, Lorient-Roudaut FM, Roudaut RP, Besse PM. Acute thrombotic obstruction with disc valve prostheses' diagnostic considerations and fibrinolytic treatment. J Am Coll Cardiol 1986;7:743-51.
29. Martinell J, Fraile J, Artiz V, Cortina J, Fresneda P, Rabago G. Reoperations for left-sided low-profile mechanical prosthetic obstructions. Ann Thorac Surg 1987;43:172-5
30. Copans H, Lakier JB, Kinsley RH, Colsen PR, Fritz VU, Barlow JB. Thrombosed Bjork-Shiley mitral prostheses. Circulation 1980;61 169-74.
31. Husebye DG, Pluth JR, Piehler JM, Schaff HV, Orszulak TA, Puga FJ, et al. Reoperation on prosthetic heart valves. An analysis of risk factors in 552 patients. J Thorac CardiovasC Surg 1983;86.543-52.
32. Devin E, Sareli P, Wisenbaugh T, Cronje SL. Obstruction of mechanical heart valve prostheses clinical aspects and surgical management. J Am Coll Cardiol 1991;17:646-50.
33. Martinell J, Jimenez A, Rabago G, Aroz V, Fraile J, Farre J Mechanical cardiac valve thrombosis. Is thrombectomy justified? Circulation 1991;84(5 Suppl):III-70-5.
34. Silber H, Khan SH, Matloff JM, Chaux A, DeRobertis M, Gray R. The St. Jude valve. Thrombolysis as the first line of therapy for cardiac valve thrombosis. Circulation 1993,87:30-7